Lindus Health Awarded Funding from ARIA to Build Safe and Reliable AI for Clinical Trial Design
Lindus Health, an anti-CRO focusing on faster, more reliable trials, has received funding from ARIA, the UK's specialized R&D funding agency. The funding will support Lindus Health in designing safe and reliable AI technologies. This collaboration aims to unlock scientific and technological breakthroughs in the healthcare industry. Lindus Health's innovative approach to clinical trials has garnered attention and support from various organizations. The partnership with ARIA underscores the potential impact of Lindus Health's work on advancing healthcare research and development.
Boston, April 3, 2025 - Lindus Health, the anti-CRO running radically faster, more reliable trials, has been awarded funding by ARIA, the UK's specialized R&D funding agency built to unlock scientific and technological breakthroughs, to design safe and reliable AI for clinical trial design as part of their Safeguarded AI program.
Transforming Clinical Trial Design Using Safe and Reliable AI
The project called "Transforming clinical trial design using safe and reliable AI," will be a collaboration between Lindus Health and Nobuko Yoshida's research group in the Department of Computer Science, University of Oxford. Safety and reliability of AI systems represent a critical barrier to innovation in safety-critical sectors like healthcare, where errors can cost lives and undermine public trust.
Today's AI systems, while powerful, lack the reliability needed for high-stakes applications such as clinical trial design, where errors could lead to undesirable outcomes. The Safeguarded AI programme aims to revolutionize AI safety by combining scientific world models with mathematical proofs to create AI systems with quantitative safety guarantees.
Lindus Health is pioneering a breakthrough AI-assisted clinical trial design system as part of this ARIA-funded project. The research will validate methods for using AI with mathematically proven safeguards to transform decision-making in trial planning.
Benefits and Impact
This collaborative work directly tackles the fragmented, inefficient processes that currently plague trial design, leading to errors and wasted historical data. The project aims to develop a solution that leverages mathematical proofing techniques to recommend best practices to clinical trial researchers while delivering verifiable safety guarantees.
The innovation promises to substantially reduce trial setup times, lower costs, and increase accuracy—ultimately accelerating the development of life-saving therapies while building much-needed trust in AI tools among clinical researchers who have been reluctant to adopt them.
Once fully validated, this approach could fundamentally reshape how the biopharmaceutical industry approaches clinical trials, making them faster, more reliable, and more accessible.
Quotes from Lindus Health and ARIA
"Poor trial design can lead to various consequences that hinder scientific innovation, from time-consuming operational tasks to clinical trial failures," said Nijat Hasanli, Head of Product at Lindus Health. "With ARIA, we're combining our AI and industry expertise to work towards eliminating these risks, setting every clinical trial up for success and transforming the way we develop medical interventions."
"AI could unlock transformative improvements in our critical infrastructure, but right now adoption is limited because without ironclad safety assurances, we risk unintended and damaging consequences," said David 'davidad' Dalrymple, Programme Director at ARIA. "Our goal is to prove that it's possible to develop AI with quantitative safety guarantees, and that this could unlock significant economic value for the UK."
About Lindus Health
Lindus Health is an anti-CRO running radically faster, more reliable clinical trials for life science pioneers – bringing ground-breaking treatments to patients more quickly. This is achieved through a commercial model that aligns incentives, a world-class clinical operations team with its unique software platform, and access to over 40 million Electronic Health Records.
Clinical trials are the biggest bottleneck to advances in healthcare. Lindus Health removes this constraint through end-to-end execution of clinical studies driven by technology and forward-thinking approaches to clinical operations.
To date, Lindus Health has delivered clinical trials across the US, UK, and Europe to tackle a range of conditions, including diabetes, asthma, acne, social anxiety, major depressive disorder, hypertension, chronic fatigue syndrome, and insomnia.
About ARIA
ARIA is the UK's specialized R&D funding agency built to unlock scientific and technological breakthroughs that benefit everyone. Created by an Act of UK Parliament and sponsored by the Department for Science, Innovation and Technology, ARIA funds teams of scientists and engineers across the United Kingdom to pursue research at the edge of what is scientifically and technologically possible.
Press contact: Jodi Perkins Amendola Communications for Lindus Health [email protected] Cell: 847.508.0877 SOURCE Lindus Health